Patents

US 9090704 B2: Protein therapy for treatment of retinal diseases

Granted
2015-07-28
Filed
2014-05-22 application 14284911
Type
Utility · 6 claims
Elsewhere
Google Patents ↗ · USPTO patent document ↗ · USPTO Patent Center record ↗

Abstract

The present invention encompasses methods, compositions, and devices for treating an ocular disease, disorder or condition in a mammal. The invention includes polypeptides that possess anti-inflammatory, anti-apoptotic, immune modulatory and anti-tumorigenic properties, and their application in the treatment of eye disease, particularly diseases of the retina. In particular aspects, the invention includes administration of a therapeutic polypeptide such as a stanniocalcin family member protein for the treatment of an eye disease. Also included are fusion proteins and cells stimulated or modified to express the therapeutic polypeptides as set forth herein.

Source: PVGPATDIS, file of 2026-04-10 (ipg150728.xml).

Assignees

AssigneeTypePlaceAlso on furp.orgSource
SCOTT & WHITE HEALTHCARE 21 patentsUS company or organizationTemple, TXSCOTT & WHITE HEALTHCARE State business registration EXACT high confidence: identical full name and state
SCOTT & WHITE HEALTHCARE Nonprofit EXACT high confidence: identical full name and state
PVGPATDIS, file of 2026-04-10
THE TEXAS A&M UNIVERSITY SYSTEM 801 patentsUS company or organizationCollege Station, TXPVGPATDIS, file of 2026-04-10

Inventors

InventorPlacePatentsPerson pageSource
Robert RosaBelton, TX7PVGPATDIS, file of 2026-04-10
Gavin W. RoddyTemple, TX7Person page FUZZY medium confidencePVGPATDIS, file of 2026-04-10
Darwin J. ProckopPhiladelphia, PA14PVGPATDIS, file of 2026-04-10

CPC categories

SubclassCategoryFirst groupSource
A61KPreparations for medical, dental or toiletry purposesA61K38/22PVGPATDIS, file of 2026-04-10
C07KPeptidesC07K14/575PVGPATDIS, file of 2026-04-10

Cooperative Patent Classification, as currently assigned (one row per subclass).

Assignments and security interests

RecordedWhatFromToReel/frameSource
2017-12-19Government interest
Confirmatory license
TEXAS A&M UNIVERSITY SYSTEM signed 2017-12-18NIH - DEITR BETHESDA, MD44906/757PASDL, file of 2026-08-13
2017-12-12Government interest
Confirmatory license
TEXAS A&M UNIVERSITY signed 2017-12-07NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT BETHESDA, MD44836/386PASDL, file of 2026-08-13
2017-07-28Assignment
Assignment of assignor's interest
PROCKOP, DARWIN J. signed 2012-12-06THE TEXAS A&M UNIVERSITY SYSTEM COLLEGE STATION, TX43125/969PASDL, file of 2026-08-13
2017-07-28Assignment
Assignment of assignor's interest
ROSA, ROBERT H., JR signed 2013-10-31SCOTT & WHITE HEALTHCARE TEMPLE, TX43125/884PASDL, file of 2026-08-13
2017-07-28Assignment
Assignment of assignor's interest
RODDY, GAVIN signed 2014-07-01THE TEXAS A&M UNIVERSITY SYSTEM COLLEGE STATION, TX43125/760PASDL, file of 2026-08-13

Documents recorded with the USPTO Assignment Recordation Branch that list this patent. A security interest is a lender’s claim on the patent as collateral; a release ends it.

USPTO bulk data: PatentsView granted patents, disambiguated (PVGPATDIS) for patents, assignees, inventors, places and CPC categories; the USPTO Patent Assignment Dataset (ECORSEXC) for assignments and security interests. Patents filed in the last 20 years. No claims or full text. Links to other records are by name (and state): EXACT means the identical full name and state; FUZZY means a looser name match, with the confidence shown.